Helicobacter pylori strain ZH28 42

Helicobacter pylori strain ZH28 42 is a Gram-negative, microaerophilic bacterium characterized by its spirilla shape and the presence of flagella, allowing for mobility in its host-associated habitat. This strain is primarily associated with various hosts, including Homo sapiens and other animal species such as Gallus gallus and several types of mammals and birds. With a single replicon and two membranes, ZH28 42 thrives optimally at 37°C within a mesophilic temperature range. It engages in free-living biotic relationships, suggesting a complex interaction within its host environments. The health effects of Helicobacter pylori strain ZH28 42 are significant, as it is associated with a range of gastrointestinal diseases, including chronic gastric inflammation, peptic ulcers, and various forms of gastric cancer, such as adenocarcinoma and mucosa-associated lymphoid tissue lymphoma. Other health issues linked to this strain include gastritis, gastroesophageal reflux disease (GERD), and functional dyspepsia, highlighting its prominent role in gastrointestinal pathology. The pathogenicity of strain ZH28 42 in humans underscores its potential impact on public health, given its association with severe gastric conditions. Understanding the characteristics and effects of this strain is crucial for developing targeted treatments and preventative measures against the diseases it causes. This strain exemplifies the complex interplay between microbial inhabitants and host health, emphasizing the need for ongoing research into the ecological roles of pathogenic bacteria in human health.